Treatment of childhood Hodgkin’s disease with chemotherapy alone

Experiences from the Royal Children’s Hospital, Melbourne
  • Henry Ekert
Part of the Cancer Treatment and Research book series (CTAR, volume 41)


The essential feature of childhood is growth and development, culminating in a mature adult. Pediatric oncologists face a particular dilemma when planning the best methods of treatment of life-threatening disease. The cure of children should be achieved at the lowest possible cost to their growth and development. Truly cured individuals are those whose physical and mental health is comparable to their age- and sex-matched peers in their social strata. In Wilms’ tumor and acute lymphocytic leukemia, the intensity of treatment, which has irreversible consequences on growth and development, is being decreased. In childhood Hodgkin’s disease, similar attempts are under way to eliminate the consequences of irradiation of growing tissues and postsplenectomy infections, and to reduce the cumulative toxicity of chemotherapy, surgery, and irradiation (Table 1).


Acute Myeloid Leukemia Complete Remission Acute Lymphocytic Leukemia Herpes Zoster Nitrogen Mustard 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Longo DL, Young RC, De Vita VT Jr: Chemotherapy for Hodgkin’s disease: the remaining challenges. Cancer Treat Rep 66:925–936, 1982.PubMedGoogle Scholar
  2. 2.
    Bonadonna G, Zucali R, Monfardini S, et al.: Combination chemotherapy of Hodgkin’s disease with adriamycin, bleomycin, vinblastine and imidazole carboxamide versus MOPP. Cancer 36:252–259, 1973.CrossRefGoogle Scholar
  3. 3.
    Bonadonna G, Santoro A, Bonfante V, Valagussa P: Cyclic delivery of MOPP and ABVD combination in stage IV Hodgkin’s disease: rationale, background studies and recent results. Cancer Treat Rep 66:881–887, 1982.PubMedGoogle Scholar
  4. 4.
    Olweny CLM, Katongole-Mbidde E, Kiive C, Lwanga SK, Magrath I, Ziegler JL: Childhood Hodgkin’s disease in Uganda: a ten year experience. Cancer 42:787–792, 1978.PubMedCrossRefGoogle Scholar
  5. 5.
    Robinson B, Kingston J, Nogueira Costa R, Malpas JS, Barrett A, McElwain TJ: Chemotherapy and irradiation in childhood Hodgkin’s disease. Arch Dis Child 59:1162–1167, 1984.PubMedCrossRefGoogle Scholar
  6. 6.
    Ekert H, Waters KD: Results of treatment of 18 children with Hodgkin’s disease with MOPP chemotherapy as the only treatment modality. Med Pediatr Oncol 11:322–326, 1983.PubMedCrossRefGoogle Scholar
  7. 7.
    Valagussa P, Santoro A, Fossati Bellani F, Franchi F, Banfi A, Bonadonna G: Absence of treatment-induced second neoplasms after ABVD in Hodgkin’s disease. Blood 59:488–494, 1982.PubMedGoogle Scholar
  8. 8.
    Dinsmore RE, Straus DJ, Pollack MS, et al.: Fatal graft-versus-host disease following blood transfusion in Hodgkin’s disease documented by HLA typing. Blood 55:831–834, 1980.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers, Boston 1989

Authors and Affiliations

  • Henry Ekert

There are no affiliations available

Personalised recommendations